ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Researchers point way to improved stem cell transplantation therapies – Medical Xpress

Medical XpressResearchers point way to improved stem cell transplantation therapiesMedical XpressResearchers in Germany have demonstrated that hematopoietic stem cell (HSC) transplants can be improved by treatments that temporarily prevent the stem cel… Continue reading

2017-09-07 Michael Zand NEWS

Barclays Starts Coverage on Editas Medicine, Inc. (EDIT) By Announcing An Initial Rating Of “Overweight” – First News 24

Continue reading

2017-09-07 Michael Zand NEWS

Barclays Starts Coverage on Editas Medicine, Inc. (EDIT) By Announcing An Initial Rating Of “Overweight” – First News 24

Barclays Starts Coverage on Editas Medicine, Inc. (EDIT) By Announcing An Initial Rating Of “Overweight”
First News 24
CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular …

and more »

Continue reading

2017-09-07 Michael Zand NEWS

Sen. Isakson applauds FDA approval of Kymriah gene therapy – Life … – Life Science Daily

Barclays Starts Coverage on Editas Medicine, Inc. (EDIT) By Announcing An Initial Rating Of “Overweight”
First News 24
CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular …

and more »

Continue reading

2017-09-07 Michael Zand NEWS

FDA approves $475000 CAR-T therapy – HealthLeaders Media

FDA approves $475000 CAR-T therapyHealthLeaders MediaThe Food and Drug Administration (FDA) approved the first gene therapy released in the U.S., Kymriah, also known as chimeric antigen receptor T-cell (CAR-T) therapy. The $475,000 treatment will be ou… Continue reading

2017-09-07 Michael Zand NEWS

FDA approves $475000 CAR-T therapy – HealthLeaders Media

FDA approves $475000 CAR-T therapyHealthLeaders MediaThe Food and Drug Administration (FDA) approved the first gene therapy released in the U.S., Kymriah, also known as chimeric antigen receptor T-cell (CAR-T) therapy. The $475,000 treatment will be ou… Continue reading

2017-09-07 Michael Zand NEWS

International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson’s Disease – Nasdaq


Life Science Daily

Sen. Isakson applauds FDA approval of Kymriah gene therapy – Life …
Life Science Daily
Sen. Johnny Isakson (R-GA) recently commended the Food and Drug Administration’s (FDA) approval of the first cell-based gene therapy available in the United …
FDA approves $475,000 CAR-T therapy | HealthLeaders MediaHealthLeaders Media

all 3 news articles »

Continue reading

2017-09-07 Michael Zand NEWS

International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson’s Disease – GlobeNewswire (press release)

International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson’s Disease
Nasdaq
07, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today reported that two more patients with …

and more »

Continue reading

2017-09-07 Michael Zand NEWS
  • 1
  • …
  • 1,237
  • 1,238
  • 1,239
  • 1,240
  • 1,241
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Washington University School of Medicine in St. Louis

International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson’s Disease
GlobeNewswire (press release)
CARLSBAD, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today reported that two …
Stem cells derived from eggs alone – studyIndependent Online
Human skin cells transformed directly into motor neuronsWashington University School of Medicine in St. Louis
Product News: Improved Stem Cell Growth Performance with Xeno-Free Cell Culture MediumSelectScience
Medical Xpress –LANews By Abhishek Budholiya (press release) (blog) –Medgadget (blog)
all 10 news articles »